Equities

Grapefruit USA Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GPFT:PKC

Grapefruit USA Inc

Actions
  • Price (USD)0.0005
  • Today's Change0.000 / 4.08%
  • Shares traded1.07m
  • 1 Year change-15.00%
  • Beta-0.2723
Data delayed at least 15 minutes, as of Feb 13 2026 16:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Grapefruit USA, Inc. is engaged in the development of its patented Hourglass Time Release Tetrahydrocannabinol (THC)+Cannabinoid (CBD)-Infused Topical Cream. Its Hourglass is the patented Full Spectrum THC+ CBD Topical delivery Cream that provides its users with a full body, synergistic entourage effect. Hourglass is available in licensed retail and mobile cannabis dispensaries in Central California and Los Angeles County, California, the United States of America. Its certified organic CBD tincture stimulates health, wellness and well-being with its organic, Keto friendly, MCT Oil. Its certified organic pet CBD tincture is a hemp-derived CBD oil made with 100% certified organic extra virgin olive oil. The Company is also engaged in retail and wholesale sales of its Summit Boys branded products in California.

  • Revenue in USD (TTM)34.85k
  • Net income in USD-4.37m
  • Incorporated2017
  • Employees9.00
  • Location
    Grapefruit USA Inc10866 Wilshire Blvd.LOS ANGELES 90024United StatesUSA
  • Phone+1 (310) 205-1382
  • Fax+1 (818) 260-0445
  • Websitehttp://imaging3.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neutra Corp66.08k-177.83k304.29k--------4.60-0.00006-0.000060.00002-0.00032.42-------652.23-401.90----64.32---269.11-1,234.68---38.69-----41.87--59.53------
Altamira Therapeutics Ltd0.00-5.65m560.12k13.00--0.1375-----1.45-1.450.000.71280.00----0.00-74.38-74.95-96.95-118.32------------0.1624-------4.53---49.17--
Grapefruit USA Inc34.85k-4.37m592.59k9.00------17.00-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
Apollo Biowellness Inc2.23m-2.00m716.90k6.00------0.3212-0.0189-0.01890.02-0.02160.6255-------56.14-371.95----65.5258.46-89.76-533.66---5.26----11,413.18---50.65------
American Green Inc-100.00bn-100.00bn868.45k6.00------------------------------------------------------------
Pure Harvest Corporate Group Inc2.48m-6.67m879.61k25.00--0.3903--0.3552-0.0901-0.09010.03830.02010.26441.4640.6499,070.40-70.96---136.76--33.83---268.37--0.5886-0.8660.7639--1,808.41---459.26------
Data as of Feb 13 2026. Currency figures normalised to Grapefruit USA Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.